Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06892197 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Aug 1, 2026 to Aug 1, 2030
    • Start date changed from estimate of Aug 1, 2025 to Mar 10, 2026
    • Study sites: 0 to 14
    • Study completion date: Nov 1, 2026 to Nov 1, 2030
  2. Enrollment target: 2000 to 1600v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this cluster randomized controlled trial is to determine the optimal treatment for community aquired pneumonia (CAP). The study compares the effects and side effects of hydrocortisone and prednisolone in patients above 18 years old diagnosed with severe CAP. The main question is whether there is a difference in all cause mortality within thirty days. Participants will be randomized to receive treatment with either hydrocortisone or prednisolone.
Trial Details
NCT Number NCT06892197
Lead Sponsor Copenhagen Respiratory Research
Conditions
(from sponsor)		 Community Acquired Pneumonia (CAP)
Related terms Community-Acquired Pneumonia
Enrollment 1,600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov